Division of Transplant Surgery, Mayo Clinic, Phoenix, AZ, United States.
Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
Transpl Int. 2022 Dec 8;35:10810. doi: 10.3389/ti.2022.10810. eCollection 2022.
Data and transplant community opinion on delayed graft function (DGF), and its impact on outcomes, remains varied. An unsupervised machine learning consensus clustering approach was applied to categorize the clinical phenotypes of kidney transplant (KT) recipients with DGF using OPTN/UNOS data. DGF was observed in 20.9% ( = 17,073) of KT and most kidneys had a KDPI score <85%. Four distinct clusters were identified. Cluster 1 recipients were young, high PRA re-transplants. Cluster 2 recipients were older diabetics and more likely to receive higher KDPI kidneys. Cluster 3 recipients were young, black, and non-diabetic; they received lower KDPI kidneys. Cluster 4 recipients were middle-aged, had diabetes or hypertension and received well-matched standard KDPI kidneys. By cluster, one-year patient survival was 95.7%, 92.5%, 97.2% and 94.3% ( < 0.001); one-year graft survival was 89.7%, 87.1%, 91.6%, and 88.7% ( < 0.001). There were no differences between clusters after accounting for death-censored graft loss ( = 0.08). Clinically meaningful differences in recipient characteristics were noted between clusters, however, after accounting for death and return to dialysis, there were no differences in death-censored graft loss. Greater emphasis on recipient comorbidities as contributors to DGF and outcomes may help improve utilization of DGF at-risk kidneys.
数据和移植界对延迟移植物功能(DGF)及其对结局的影响的看法仍然存在差异。本研究应用无监督机器学习共识聚类方法,利用 OPTN/UNOS 数据对 DGF 肾移植(KT)受者的临床表型进行分类。在 KT 中观察到 20.9%(=17073)发生 DGF,大多数肾脏的 KDPI 评分<85%。确定了四个不同的聚类。第 1 组受者为年轻、高 PRA 的再次移植受者。第 2 组受者为年龄较大的糖尿病患者,更有可能接受 KDPI 评分较高的肾脏。第 3 组受者为年轻、黑人、非糖尿病患者,他们接受的 KDPI 评分较低的肾脏。第 4 组受者为中年,患有糖尿病或高血压,接受匹配良好的标准 KDPI 肾脏。按聚类计算,1 年患者生存率分别为 95.7%、92.5%、97.2%和 94.3%(<0.001);1 年移植物生存率分别为 89.7%、87.1%、91.6%和 88.7%(<0.001)。在考虑死亡相关移植物丢失(=0.08)后,各聚类之间无差异。然而,在考虑死亡和返回透析后,各聚类之间在死亡相关移植物丢失方面无差异。更加强调受者合并症是导致 DGF 和结局的原因,可能有助于改善 DGF 高危肾脏的利用。